BA
PBYI icon

BlackRock Advisors’s Puma Biotechnology PBYI Stock Holding History

BlackRock Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.08M Buy
67,799
+13,679
+25% +$591K ﹤0.01% 1490
2016
Q3 		$3.63M Buy
54,120
+40,214
+289% +$2.03M ﹤0.01% 1234
2016
Q2 		$414K Buy
13,906
+2,024
+17% +$63.3K ﹤0.01% 2220
2016
Q1 		$349K Hold
11,882
– – ﹤0.01% 2259
2015
Q4 		$932K Sell
11,882
-22,692
-66% -$1.78M ﹤0.01% 1751
2015
Q3 		$2.6M Sell
34,574
-88,703
-72% -$8.39M ﹤0.01% 1280
2015
Q2 		$14.4M Sell
123,277
-48,312
-28% -$8.75M 0.02% 645
2015
Q1 		$40.5M Sell
171,589
-38,236
-18% -$8.17M 0.04% 361
2014
Q4 		$39.7M Sell
209,825
-21,421
-9% -$4.75M 0.04% 383
2014
Q3 		$55.2M Sell
231,246
-58,014
-20% -$11.9M 0.05% 326
2014
Q2 		$19.1M Sell
289,260
-15,495
-5% -$1.1M 0.02% 577
2014
Q1 		$31.7M Buy
304,755
+136,840
+81% +$16.1M 0.03% 449
2013
Q4 		$17.4M Sell
167,915
-136,726
-45% -$8.02M 0.02% 592
2013
Q3 		$16.3M Sell
304,641
-264,199
-46% -$14.2M 0.02% 627
2013
Q2 		$25.2M Buy
+568,840
New +$20.1M 0.03% 469

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BlackRock Advisors's PBYI Position: Q4 2016 in Review

BlackRock Advisors increased its Puma Biotechnology (PBYI) stake by 25% in Q4 2016, buying an estimated $591K and bringing the position to 67,799 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1490.

BlackRock Advisors first reported a position in PBYI in Q2 2013 and has held it in 15 quarters since. The position peaked at $55.2M in Q3 2014. 128 funds tracked by Wall St. Rank hold PBYI as of Q4 2016.

  • BlackRock Advisors held 67,799 shares of Puma Biotechnology worth $2.08M as of Q4 2016.
  • BlackRock Advisors bought 13,679 Puma Biotechnology shares in Q4 2016, an estimated $591K.
  • Puma Biotechnology made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1490 holding.
  • BlackRock Advisors first reported a position in Puma Biotechnology in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Puma Biotechnology position peaked at $55.2M in Q3 2014.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.